Chia-Yen Dai, MD, Ms
Kaohsiung Municipal Hsiao-Kang Hospital
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming-Lung Yu, MD, PhD
Kaohsiung Medical University
Shared therapeutic areas:
Worked with same sponsors:
Chang-Fu Chiu, MD
Paochien Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jee-Fu Huang, MD
Foo Yin Hospital
Shared therapeutic areas:
Worked with same sponsors:
Mostafa Gabr, MD
Cairo University
Shared therapeutic areas:
Emily Y Chew, M.D.
National Eye Institute (NEI)
Shared therapeutic areas:
Wahid Doss, MD
Cairo University
Shared therapeutic areas:
Mohamed A Afify, MD
Cairo University
Shared therapeutic areas:
Gamal Sheha, MD
Cairo University
Shared therapeutic areas:
Noaman Al-Garem, MD
Cairo University
Shared therapeutic areas:
Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
All 2 trials loaded